Cardiology

Men and women get sick in different ways

At the dawn of third millennium medical researchers still know very little about gender-specific differences in illness, particularly when it comes to disease symptoms, influencing social and psychological factors, and the ...

Oncology & Cancer

Discovering the secrets of tumor growth

Scientists at the University of Copenhagen's Center for Healthy Ageing have identified a compound that blocks the expression of a protein without which certain tumours cannot grow. This compound has the potential as an anticancer ...

HIV & AIDS

New handheld mobile device performs laboratory-quality HIV testing

New research appearing online today in Clinical Chemistry, the journal of AACC, shows that a handheld mobile device can check patients' HIV status with just a finger prick, and synchronize the results in real time with electronic ...

Medical research

Designing a new drug for chronic pain

(Medical Xpress)—Scientists at the University of Liverpool and the Royal Liverpool University Hospital have been awarded £1.4 million to design a new drug for the treatment of chronic pain.

Alzheimer's disease & dementia

New Alzheimer's marker strongly predicts mental decline

A new marker of Alzheimer's disease can predict how rapidly a patient's memory and other mental abilities will decline after the disorder is diagnosed, researchers at Washington University School of Medicine in St. Louis ...

Medications

New antibiotic compound enters phase I clinical trial

(Medical Xpress) -- Novacta Biosystems has commenced dosing of the first healthy volunteers in a phase I clinical trial of a new antibiotic to treat the hospital superbug Clostridium difficile.

Health

Grapes protect against ultraviolet radiation

Some compounds found in grapes help to protect skin cells from the sun's ultraviolet radiation, according to a study by researchers from the University of Barcelona and the CSIC (Spanish National Research Council). The study ...

Medical research

UCSF botulism research translates into bioterrorism treatment

(Medical Xpress) -- UCSF basic research into botulism has translated into a novel antitoxin to protect against bioterrorism, with the first clinical trials launching soon to assess the resulting vaccine's safety.

page 3 from 3